CompletedPhase 3

Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy

Pakistan200 participantsStarted 2019-03-04

Plain-language summary

A total of 200 women for elective abdominal myomectomy were randomly allocated into two groups. 100 women in experimental group were administered 400ug Misoprostol (2 tablets of Prosotec®) through the rectal route prior to surgery and 100 were in control group, in which no drug was administered.

Who can participate

Age range18 Years – 50 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. ASA physical status class I-II
✓. Intramural or subserosal fibroids - diagnosed on ultrasound
✓. Candidates for elective abdominal myomectomy

Exclusion criteria

✕. Pre-operative Hemoglobin \< 10 g/dl
✕. Patient who received Danazol or GnRH analogues before surgery
✕. No other systemic or metabolic disease

What they're measuring

Intraoperative blood loss

Timeframe: During the surgical procedure

Trial details

NCT IDNCT05108597

SponsorPak Emirates Military Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2020-03-04

View on ClinicalTrials.gov More Blood Loss, Surgical trials